MCM
PAHC icon

Matarin Capital Management’s Phibro Animal Health PAHC Stock Holding History

Matarin Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-8,118
Closed -$301K – 301
2017
Q2 		$301K Hold
8,118
– – 0.03% 245
2017
Q1 		$228K Buy
+8,118
New +$229K 0.02% 263

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
VFA
Virtus Fund Advisers Hartford, Connecticut $32.1M AUM 39.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CRCP
Copper Rock Capital Partners Boston, Massachusetts $296M AUM 28.61% 1-Year Est. Return
DIA
Denver Investment Advisors Denver, Colorado $1.89B AUM 7.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Matarin Capital Management's PAHC Position: Q3 2017 in Review

Matarin Capital Management sold out of Phibro Animal Health (PAHC) in Q3 2017, closing a stake of 8,118 shares — an estimated $301K sold.

Matarin Capital Management first reported a position in PAHC in Q1 2017 and held it in 2 quarters. The position peaked at $301K in Q2 2017. 164 funds tracked by Wall St. Rank hold PAHC as of Q3 2017.

  • Matarin Capital Management reported no remaining Phibro Animal Health position as of Q3 2017 after selling out during the quarter.
  • Matarin Capital Management sold 8,118 Phibro Animal Health shares in Q3 2017, an estimated $301K.
  • Matarin Capital Management first reported a position in Phibro Animal Health in Q1 2017 and held it in 2 quarters.
  • Matarin Capital Management's Phibro Animal Health position peaked at $301K in Q2 2017.
  • 164 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2017.

Based on Matarin Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.